- Home
- About Us
- Divisions
- Adolescent and Young Adult Medicine
- Allergy and Immunology
- Blood and Marrow Transplantation and Cellular Therapies
- Cardiology
- Child Advocacy
- Emergency Medicine
- Endocrinology
- Gastroenterology, Hepatology and Nutrition
- General Academic Pediatrics
- Genetic and Genomic Medicine
- Health Informatics
- Hematology-Oncology
- Infectious Diseases
- Nephrology
- Neurology and Child Development
- Newborn Medicine
- Paul C. Gaffney Division of Pediatric Hospital Medicine
- Pulmonology
- Rheumatology
- Centers & Institutes
- Center for Pediatric Research in Obesity and Metabolism
- Center for Rare Disease Therapy
- Children's Neuroscience Institute
- Cystic Fibrosis Research Center
- Institute for Infection, Inflammation, and Immunity in Children
- Pediatric Asthma Center
- Pediatric Institute for Heart Regeneration and Therapeutics
- Richard King Mellon Foundation Institute for Pediatric Research
- Pittsburgh Vaccine Trials Unit
- The Pittsburgh Study
- Research
- Diversity
- Education
- Faculty Affairs
- News
- People
- Podcasts
Jean M. Tersak, MD
- Professor of Pediatrics and Clinical and Translational Science
Administrative Assistant: Dominique White
Tersak is Board Certified in Pediatrics and in Pediatric Hematology/Oncology. She provides care for pediatric oncology patients and long term survivors of childhood cancer. She is extensively involved in clinical research including the evaluation and treatment of patients with new diagnosis and research in the area of medical late effects and quality of life in childhood cancer survivors.
Professional and Scientific Society Memberships
- American Medical Association, 1999-2014
- American Society of Pediatric Hematology and Oncology, 1999-2014
- American Society of Clinical Oncology Children’s Oncology Group, 2000-Present
Education & Training
- BS, University of Pittsburgh, 1986
- MA, University of Pittsburgh, 1989
- MD, University of Pittsburgh, 1993
- Resident, UPMC Children's Hospital of Pittsburgh, 1996
- Fellow, UPMC Children's Hospital of Pittsburgh, 1999
Selected Publications
Nesbit CE, Tersak JM, Grove LE, Drzal A, Choi H and Prochownik EV. Genetic dissection of c- myc apoptotic pathways. Oncogene. 2000 19:3200-3212.
Shenoy S, Mohanakumar T, Chatila T, Tersak JM, Wang R and Russell H. The role of IL2 in human Tcell resistance to apoptosis. Clin Immunol. 2001 May;99(2):266-275.
Rolston R, Weck KE, Tersak JM, Sherer ME, Cumbie K and Shekhter-Levin S. A new cytogenetic variant, insertion (15;17) (q22; q12q21), in an adolescent with acute promyelocytic leukemia. Cancer Genet Cytogenet.2002 Apr 1;134(1):55-59.
Mitby P, Robison L, Whitton J, Zevon M, Gibbs I, Tersak JM, Meadows A, Stovall M, Zeltzer L and Mertens A: Utilization of special education services and educational attainment among long- term survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. Cancer. 2003 Feb 15; 97(4):1115-1126.
Nagarajan R, Neglia J, Clohisy D, Yasui Y, Greenberg M, Hudson M, Zevon M, Tersak JM, Ablin A and Robison LL. Education, employment, insurance and marital status among 694 survivors of pediatric lower extremity bone tumors: a report from the childhood cancer survivor study. Cancer. 2003 May 15;97(10):2554-64.
Bhatia S, Yasiu Y, Robison L, Birch J, Bogue MK, Diller L, DeLaat C, Fossati-Belani F, Morgan E, Oberlin O, Reaman G, Ruymann FB, Tersak JM and Meadows AT. High risk of subsequent neoplasms continues with extended follow-up of childhood Hodgkin disease: report from the Late Effects Study Group (LESG). J Clin Onc. Dec 1, 21(23):4386-4394, 2003.
Deutsch M, Tersak JM. Radiotherapy for symptomatic bone metastases in children. Am J Clin Oncol. 2004 Apr;27(2):128-31.
Gurney JG, Tersak JM, Ness KK, Landier, Matthay KK, Schmidt ML. Hearing loss,quality of life and academic problems in long term neuroblastoma survivors: a report from the Children’s Oncology Group. Pediatrics. 2007 Nov;120(5): e1229-36.
Jakacki, RI, Hamilton M, Gilbertson RJ, Blaney SM, Tersak JM, Krailo MD, Ingle AM, Voss JD, Dancey JE, Adamson PC. Pediatric phase I and pharmacokinetic study of erlotinib followed by the combination of erlotinib and temozolomide: a Children’s Oncology Group Phase I Consortium Study. J Clin Oncol. 2008 Oct 20;26(30):4921-7.
Thompson AL, Marsland AL, Marshal MP and Tersak JM. Romantic relationships of emerging adult survivors of childhood cancer. Psychooncology. 2009 Jul;18(7):767-74.